Hepion Pharmaceuticals, Inc. (HEPA)

NASDAQ: HEPA · IEX Real-Time Price · USD
0.720
+0.091 (14.54%)
At close: Aug 8, 2022 4:00 PM
0.690
-0.030 (-4.153%)
After-hours: Aug 8, 2022 6:52 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20212020201920182017201620152014
Selling, General & Admin
10.018.154.5973.365.795.561.36
Research & Development
20.4123.187.597.1615.028.40.31
Operating Expenses
30.420.157.7714.5910.5220.8113.961.67
Operating Income
-30.4-20.15-7.77-14.59-10.52-20.81-13.96-1.67
Interest Expense / Income
0.010.030.550.340000.01
Other Expense / Income
2.310.15-0.38-4.95-1.06-3.818.233.6
Pretax Income
-32.72-20.32-7.95-9.99-9.46-17-22.19-5.28
Income Tax
00.03-0.91-0.54-1.95000
Net Income
-32.72-20.35-7.04-9.45-7.51-17-22.19-5.28
Preferred Dividends
00.015.448.450000
Net Income Common
-32.72-20.36-12.48-17.9-7.51-17-22.19-5.28
Shares Outstanding (Basic)
7010200000
Shares Outstanding (Diluted)
7010200000
Shares Change
626.32%373.65%1011.19%32.99%186.13%24.39%69.72%-
EPS (Basic)
-0.47-2.10-6.11-97.35-54.60-352.80-571.20-229.60
EPS (Diluted)
-0.47-2.10-6.11-97.35-54.60-352.80-571.20-229.60
Free Cash Flow Per Share
-0.45-1.68-3.73-85.08-59.38-342.74-251.13-60.24
Effective Tax Rate
0.00%-0.15%11.44%5.37%20.59%0.00%0.00%0.00%
EBITDA
-32.63-20.26-7.36-9.63-9.45-16.98-22.18-5.27
Depreciation & Amortization
0.090.030.030.020.010.020.020
EBIT
-32.71-20.29-7.39-9.65-9.46-17-22.19-5.27
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).